- Report
- November 2020
- 86 Pages
North America
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- November 2020
- 86 Pages
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- November 2020
- 90 Pages
Asia Pacific
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- November 2020
- 90 Pages
Europe
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- November 2020
- 87 Pages
Middle East, Africa
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- October 2020
- 141 Pages
Global
From €3076EUR$3,185USD£2,632GBP
€4394EUR$4,550USD£3,761GBP
- Report
- June 2019
- 154 Pages
Europe
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- June 2019
- 152 Pages
Asia Pacific
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- March 2019
- 142 Pages
North America
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- September 2021
- 115 Pages
Global
From €4346EUR$4,500USD£3,719GBP
- Report
- May 2022
- 110 Pages
Global
From €4298EUR$4,450USD£3,678GBP
- Report
- November 2018
- 105 Pages
Global
From €4298EUR$4,450USD£3,678GBP
- Report
- April 2018
- 75 Pages
Global
From €3960EUR$4,100USD£3,389GBP
- Report
- September 2019
- 13 Pages
Global
€9658EUR$10,000USD£8,265GBP
- Report
- September 2019
- 12 Pages
Global
€9658EUR$10,000USD£8,265GBP
- Report
- September 2019
- 13 Pages
Global
€9658EUR$10,000USD£8,265GBP
- Report
- September 2019
- 12 Pages
Global
€9658EUR$10,000USD£8,265GBP
- Report
- September 2019
- 13 Pages
Global
€9658EUR$10,000USD£8,265GBP
- Report
- December 2018
- 15 Pages
Global
From €9658EUR$10,000USD£8,265GBP
- Report
- December 2018
- 12 Pages
Global
From €9658EUR$10,000USD£8,265GBP
The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more